* Sanara Medtech Inc SMTI.OQ SMTI.O is expected to show
a rise
in quarterly revenue when it reports results on May 15.
* The Fort Worth Texas-based company is expected to report
a
107.4% increase in revenue to $16.2 million from $7.81 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Sanara Medtech Inc
is for
a loss of 33 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Sanara
Medtech
Inc is $60, above its last closing price of $41.05.
This summary was machine generated May 12 at 23:44 GMT. All
figures in US dollars unless otherwise stated